Abstract
Introduction: Systemic arterial hypertension (SAH) is a highly prevalent disease in the adult population. Morphological and functional cardiac impairments are frequent, and if not contained, they can result in heart failure, favoring a poor prognosis. The search for a more efficient pharmacological and non-pharmacological therapy has been constant. In this regard, monotherapy with AT1 rec…